MP04-17 BURDEN OF SYSTEMIC COMORBIDITIES USING THE ACTIONS PHENOTYPE PREDICTS DISCONTINUATION OF UROLOGIC MEDICATIONS FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE | Zendy

AI Assistant Blog Pricing

MP04-17 BURDEN OF SYSTEMIC COMORBIDITIES USING THE ACTIONS PHENOTYPE PREDICTS DISCONTINUATION OF UROLOGIC MEDICATIONS FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.